Bayesian Capital Management, LP
- SEC CIK
- 0001632551
- Latest filing
- Aug 14, 2026
EXAS holding history
Exact Sciences Corp in every 13F filed by Bayesian Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EXAS overviewAll 13F holders of EXASFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −5,922−100.0% | Sold out | Holders |
| Q4 2025 | 5,922 | $601.4K | 1.4% | +5,922 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −23,013−100.0% | Sold out | Holders |
| Q1 2025 | 23,013 | $996.2K | 0.2% | +23,013 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −4,723−100.0% | Sold out | Holders |
| Q3 2024 | 4,723 | $321.7K | <0.1% | +4,723 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −23,120−100.0% | Sold out | Holders |
| Q1 2024 | 23,120 | $1.60M | 0.2% | +1,900+9.0% | Added | Holders |
| Q4 2023 | 21,220 | $1.57M | 0.2% | +16,202+322.9% | Added | Holders |
| Q3 2023 | 5,018 | $342.3K | <0.1% | −15,900−76.0% | Reduced | Holders |
| Q2 2023 | 20,918 | $1.96M | 0.2% | +20,918 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −19,025−100.0% | Sold out | Holders |
| Q4 2022 | 19,025 | $941.9K | 0.1% | +2,225+13.2% | Added | Holders |
| Q3 2022 | 16,800 | $546.0K | 0.1% | +16,800 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −5,700−100.0% | Sold out | Holders |
| Q3 2021 | 5,700 | $544.0K | 0.2% | +5,700 | New | Holders |